| Molecule | Cat. No. | Product Name | Art | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| IL-22 | Cynomolgus IL-22 Protein, His Tag (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $360.00 50ug | |||
| IL-22 | AvitagAIDD‑Ready IL2-C82E3 | Biotinylated Cynomolgus IL-22 Protein, His,Avitag™ (MALS verified & SPR verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| IL-22 | Human IL-22 Protein, His Tag, low endotoxin (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 50ug | |||
| IL-22 | AvitagAIDD‑Ready IL2-H8247 | Biotinylated Human IL-22 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| IL-22 | Mouse IL-22 Protein, His Tag (HPLC & SPR verified) | Mouse | HEK293 | ![]() | HPLCSDS-PAGE | $360.00 50ug | |||
| IL-22 | AvitagAIDD‑Ready IL2-M82E3 | Biotinylated Mouse IL-22 Protein, His,Avitag™ (MALS & SPR verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | ||
| IL-22 | Rat IL-22 Protein, His Tag (MALS & SPR verified) | Rat | HEK293 | ![]() | MALSSDS-PAGE | $360.00 50ug |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Rose Bengal disodium | PV-10; PH-10 | Phase 3 Clinical | Provectus | Acanthamoeba Keratitis; Breast Neoplasms; Candidiasis; Carcinoma, Hepatocellular; Cigarette Smoking; Colonic Neoplasms; Colorectal Neoplasms; Dermatitis, Atopic; Keratitis; Liver Neoplasms; Lung Neoplasms; Melanoma; Metastatic breast cancer; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Plaque psoriasis; Psoriasis; Skin Melanoma; Uveal melanoma | Details |
| Temtokibart | ARGX-112; LEO-138559; LP-0145 | Phase 2 Clinical | Argenx Se, Leo Pharma Inc | Dermatitis, Atopic | Details |
| AMT-126 | AMT-126 | Phase 1 Clinical | Applied Molecular Transport | Details |
